NCT07133633View on ClinicalTrials.gov

A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

PHASE2RecruitingINTERVENTIONAL

Enrollment

315

Participants

Timeline

Start Date

September 26, 2025

Primary Completion Date

June 15, 2027

Study Completion Date

February 5, 2030

Conditions

Radiographic Axial Spondyloarthritis

Interventions

DRUG

Tulisokibart

Subcutaneous (SC) administration

DRUG

Placebo

SC administration

Trial Locations (3)

16635

RECRUITING

Altoona Center for Clinical Research ( Site 0004), Duncansville

33180

RECRUITING

Arthritis and Rheumatic Disease Specialties ( Site 0016), Aventura

91360-3967

RECRUITING

Cohen Medical Centers ( Site 0034), Thousand Oaks

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT07133633 - A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013) | Biotech Hunter | Biotech Hunter